human
bodi
mani
innat
receptor
probabl
evolv
sens
microbi
product
nucleic
acid
microbi
cellsurfac
macromolecul
pathogen
commens
organ
receptor
also
known
sens
endogen
molecul
may
present
inappropri
time
place
form
exampl
sever
class
receptor
sens
pathogen
nucleic
acid
also
respond
endogen
dna
aris
cell
e
latz
bonn
germani
open
proceed
introduc
nucleic
receptor
innat
immun
system
highlight
import
receptormedi
traffick
dna
intracellular
compart
certain
inflammatori
respons
tolllik
receptor
tlr
known
structur
studi
facilit
assembl
larg
aggreg
adaptor
form
scaffold
assembl
subsequ
compon
tlr
signal
inde
assembl
receptor
signal
molecul
larg
multimer
complex
common
thread
biolog
signal
transduct
discoveri
character
one
aggreg
call
myddosom
provid
new
insight
mechan
regul
signal
transduct
myddosom
highli
oligomer
signal
scaffold
assembl
sequenti
death
domain
receptor
signal
adaptor
protein
kinas
complex
variabl
stoichiometri
drive
format
larg
signal
macrocomplex
assembl
process
probabl
involv
posit
cooper
take
place
lipidrich
membran
microdomain
find
import
implic
therapeut
target
tlr
pathway
diseas
divers
rheumatoid
arthriti
neurodegener
n
gay
cambridg
uk
suggest
effect
therapi
need
target
critic
proteinprotein
interact
myddosom
receptor
domain
heart
assembl
whose
initi
interact
weak
probabl
readili
disrupt
signal
specif
probabl
achiev
local
kinas
ubiquitin
ligas
substrat
protein
scaffold
inde
ubiquitin
ligas
key
role
regul
signal
mani
biolog
process
includ
initi
progress
mainten
immun
use
mice
target
gene
pellegrini
melbourn
australia
character
critic
role
newli
identifi
ligas
maintain
immun
system
quiescent
state
absenc
ligas
caus
late
embryon
death
due
overwhelm
immun
activ
seem
function
dendrit
cell
dc
termin
spuriou
respons
transcript
factor
defici
ligas
result
enhanc
protract
transcript
respons
driven
subunit
sensor
infect
belong
nodlik
receptor
famili
protein
report
recogn
pathogen
well
steril
inflammatori
stimuli
crystal
via
activ
kupz
melbourn
australia
identifi
character
previous
unknown
vivo
pathway
salmonella
enterica
serovar
typhimurium
typhimurium
elicit
cytokin
product
distinct
lymphocyt
subset
involv
inflammasomemedi
recognit
bacteria
dc
although
known
time
distinct
cytokin
critic
control
clinic
experiment
infect
typhimurium
exact
regul
secret
infect
remain
unclear
inflammasomemedi
mechan
invok
intric
crosstalk
dc
respond
lymphocyt
subset
activ
pathway
substanti
effect
abil
infect
mice
control
replic
typhimurium
vivo
discuss
anoth
gramneg
pathogen
helicobact
pylori
kaparaki
melbourn
australia
report
use
bacteri
outer
membran
vesicl
mean
deliv
bacteri
product
cytoplasm
content
outer
membran
vesicl
enter
compart
recognit
cytosol
patternrecognit
receptor
occur
lead
autophagi
inflamm
immun
respons
gut
c
mackay
melbourn
australia
show
import
chemoattract
receptor
normal
regul
inflammatori
respons
particularli
lower
gut
prevent
inflammatori
bowel
diseas
express
innatetyp
immunerespons
cell
bind
shortchain
fatti
acid
acet
produc
gut
bacteri
ferment
dietari
fiber
mackay
propos
diet
makeup
intestin
microbiota
bacteri
product
acet
may
account
chang
incid
asthma
autoimmun
diseas
develop
countri
interestingli
acet
emerg
import
factor
produc
certain
probiot
strain
although
innat
immun
system
evolv
gener
rapid
effect
inflammatori
respons
invad
infecti
organ
surpris
mani
microbi
pathogen
evolv
avoid
detect
system
andor
deactiv
immun
respons
c
roy
new
connecticut
usa
present
work
legionella
pneumophila
caus
agent
legionnair
diseas
demonstr
opportunist
accident
intracellular
pathogen
stimul
almost
everi
pathway
innat
immun
respons
infect
subsequ
replic
inde
l
pneumophila
proven
use
tool
studi
innat
immun
respons
particularli
inflammasom
recogn
l
pneumophila
l
pneumophila
environment
organ
whose
natur
host
unicellular
eukaryot
bacterium
thu
evolv
avoid
detect
mammalian
immun
system
contrast
close
relat
organ
coxiella
burnetii
caus
q
fever
highli
adapt
host
evad
detect
immun
system
via
mechan
poorli
appreci
pathogen
transloc
virul
effector
protein
host
cell
use
doticm
type
iv
secret
system
yet
effector
protein
repertoir
two
organ
differ
adapt
c
burnetii
mammalian
host
evid
abil
inhibit
mammalian
proapoptot
signal
c
burnetii
doticm
effector
ankg
bind
host
protein
inhibit
apoptosi
dc
wherea
l
pneumophila
lack
effector
induc
rapid
apoptosi
dc
work
c
burnetii
doticm
effector
undoubtedli
identifi
addit
mechan
host
adapt
microbi
evas
immun
respons
new
inform
hostcel
invas
intracellular
pathogen
typhimurium
present
r
teasdal
brisban
australia
show
still
much
learn
dynam
interact
host
pathogen
enabl
typhimurium
form
intracellular
nich
invad
host
typhimurium
stimul
process
similar
macropinocytosi
mediat
uptak
cell
screen
hostcel
protein
involv
macropinocytosi
use
small
interf
knockdown
pharmacolog
inhibit
research
discov
phosphatidylinositol
kinas
pikfyv
essenti
replic
typhimurium
insid
product
kinas
phosphatidylinositol
bisphosph
requir
fusion
macropinosom
larg
vesicl
fill
extracellular
fluid
form
macropinocytosi
late
proper
matur
vacuol
screen
also
identifi
role
famili
sort
nexin
macropinosom
format
initi
stage
typhimurium
infect
sever
present
describ
ongo
battl
clearanc
immun
system
subvers
immun
respons
virus
new
aspect
host
respons
report
beard
adelaid
australia
use
transcriptom
analysi
liver
infect
hepat
c
viru
hcv
show
interferonstimul
gene
product
viperin
member
interferoninduc
transmembran
famili
protein
distinct
antihcv
properti
act
via
inhibit
viral
replic
entri
respect
therebi
rais
new
possibl
target
chronic
hcv
infect
lemon
chapel
hill
north
carolina
usa
contrast
abil
hcv
avoid
immun
respons
clearanc
hepat
viru
mean
identifi
character
viral
evas
strategi
virus
use
seri
virusproduc
proteas
target
critic
element
innat
respons
machineri
yet
surprisingli
seem
hepat
viru
evas
chimpanze
model
hepat
infect
elicit
minim
interferon
respons
result
suggest
although
virus
evolv
evas
strategi
target
innat
immun
mechan
surviv
subsequ
clearanc
reli
distinct
explor
viru
interact
z
yuan
shanghai
china
describ
variou
strategi
use
hepat
b
viru
hbv
evad
host
immun
respons
liver
biopsi
patient
infect
hbv
obtain
treatment
shown
hbv
use
least
two
mechan
avoid
innat
immun
respons
first
impair
tlrinduc
cytokin
express
correl
higher
express
hbv
surfac
antigen
inhibit
jnk
kinas
pathway
second
hbv
polymeras
inhibit
phosphoryl
dimer
nuclear
local
transcript
factor
dampen
immun
respons
togeth
studi
suggest
hbv
target
signal
innat
immun
respons
evad
detect
immun
system
establish
chronic
infect
report
twist
evas
immun
system
hepat
virus
g
ebert
munich
germani
har
abil
small
interf
rna
trigger
innat
immun
interferon
respons
research
use
small
interf
rna
design
silenc
hbv
replic
concert
interferon
product
suppress
hbv
replic
cellcultur
transgen
hbvinfect
model
provid
hope
modul
immun
respons
clear
chronic
infect
new
insight
immun
regul
old
molecul
interferon
constantli
acquir
progress
understand
biolog
type
iii
interferon
led
consider
advanc
understand
immun
okeef
melbourn
australia
discuss
cellular
specif
product
express
receptor
cell
immun
respons
studi
other
shown
express
receptor
ubiquit
like
receptor
member
interferon
famili
instead
restrict
epitheli
cell
describ
also
plasmacytoid
dc
pdc
contrast
interferon
seem
produc
restrict
subset
dc
respons
specif
ligand
synthet
rna
duplex
poli
c
make
nonubiquit
protein
immun
respons
subtl
differ
may
account
divers
immun
function
attribut
newli
identifi
cytokin
thompson
melbourn
australia
elabor
role
pathogenesi
therapeut
respons
hcv
genomewid
associ
studi
identifi
polymorph
region
encod
chromosom
correl
well
treatment
outcom
patient
infect
hcv
genotyp
treat
coval
attach
polyethylen
glycol
polym
chain
patient
carri
goodrespons
variant
enhanc
phaseon
kinet
two
threefold
higher
rate
viral
erad
furthermor
differ
patient
differ
ethnic
background
allel
frequenc
explain
much
recogn
ethnic
dispar
cure
moreov
polymorph
also
associ
spontan
clearanc
hcv
underli
biolog
mechan
howev
remain
unclear
provid
import
area
futur
research
evid
adapt
microb
host
environ
appar
genom
approach
understand
buruli
ulcer
emerg
neglect
tropic
diseas
diseas
subcutan
tissu
affect
human
anim
caus
infect
mycobacterium
ulceran
vaccin
stinear
melbourn
australia
use
genom
address
key
research
issu
includ
ulceran
transmit
human
use
multistrain
compar
genom
group
shown
ulceran
evolv
close
relat
mycobacterium
marinum
later
gene
transfer
genom
reduct
gene
found
ulceran
close
relat
mycobacteria
predict
encod
antigen
recombin
protein
deriv
gene
seem
elicit
specif
serum
antibodi
respons
human
live
region
buruli
ulcer
suggest
may
possibl
use
serolog
assess
exposur
bacterium
k
holt
melbourn
australia
discuss
studi
microevolut
shigella
sonnei
common
agent
endem
dysenteri
wholegenom
sequenc
phylogenet
analysi
collect
isol
global
sourc
categor
popul
sever
distinct
cluster
recent
isol
restrict
singl
cluster
analysi
isol
ho
chi
minh
citi
shown
nearli
local
case
attribut
local
expans
singl
clone
similar
rapid
microbi
adapt
evid
subsaharan
africa
distinct
sequenc
type
typhimurium
emerg
frequent
caus
invas
diseas
levin
baltimor
maryland
usa
report
high
diseas
burden
case
fatal
caus
strain
made
vaccin
develop
urgent
prioriti
emerg
discov
comprehens
surveil
program
highlight
import
monitor
infecti
diseas
vulner
popul
microb
also
form
unusu
interact
host
bat
serv
reservoir
mani
emerg
virus
includ
paramyxovirus
hendra
nipah
virus
coronavirus
sever
acut
respiratori
syndrom
coronavirus
filovirus
ebola
marburg
virus
wild
bat
popul
experiment
infect
bat
howev
show
clinic
sign
diseas
work
l
wang
geelong
australia
focus
understand
virusbat
interact
perspect
genom
transcriptom
express
profil
consider
progress
also
made
establish
bat
cell
line
function
studi
key
molecul
bat
innat
immun
tlr
interferon
system
ultim
fundament
investig
may
help
explain
bat
seem
asymptomat
carrier
virus
deadli
human
effect
immun
respons
requir
order
sequenti
express
secret
inflammatori
cytokin
appropri
cell
j
stow
brisban
australia
use
livecel
imag
show
cytokin
traffic
recycl
endosom
macrophag
allow
orchestr
releas
multipl
cytokin
secretori
lysosom
pathway
studi
demonstr
recycl
endosom
coordin
cytokin
releas
allow
macrophag
engulf
destroy
invad
pathogen
macrophag
activ
induct
robust
immun
respons
critic
gener
protect
immun
mycobacterium
tuberculosi
b
saunder
sydney
australia
propos
macrophag
use
previous
unknown
commun
strategi
involv
releas
microparticl
stress
induc
bacillu
microparticl
contain
tuberculosi
antigen
process
antigenpres
cell
therebi
induc
antigenspecif
cell
respons
therefor
microparticl
may
repres
mode
immunolog
transfer
induc
cell
migrat
inflammatori
respons
infect
tuberculosi
signaltransduct
program
core
cell
innat
immun
respons
macrophag
mediat
key
transcript
factor
irf
protein
exampl
control
differenti
macrophag
mice
p
pitha
baltimor
maryland
usa
discuss
phenotyp
mice
includ
b
cell
abnorm
propens
develop
autoimmun
find
underscor
role
key
transcript
genet
program
interfac
innat
adapt
immun
system
factor
mediat
innat
respons
mrna
microrna
cell
innat
immun
system
macrophag
whose
coordin
induct
present
forster
melbourn
australia
addit
function
anoth
innat
cell
type
pdc
report
ang
melbourn
australia
although
pdc
recogn
role
produc
type
interferon
viral
infect
pdc
also
shown
combat
intracellular
bacteri
pathogen
l
pneumophila
deplet
pdc
mice
infect
l
pneumophila
exacerb
wherea
supplement
pdc
lung
amelior
infect
diminish
bacteri
load
notabl
resist
pulmonari
l
pneumophila
infect
independ
type
interferon
signal
show
pdc
control
bacteri
infect
lung
mechan
distinct
antivir
pathway
type
interferon
summari
present
confirm
idea
presenc
pathogenassoci
stimul
molecul
detect
cell
innat
immun
system
drive
signal
product
cytokin
contextdepend
manner
shape
natur
respons
ensu
innat
sculpt
adapt
immun
occur
cytokin
potent
immunosuppress
cytokin
widerang
effect
cell
b
cell
well
cell
innat
immun
respons
macrophag
dc
tropic
diseas
viscer
leishmaniasi
character
splenomegali
remodel
red
white
pulp
compart
spleen
local
immunosuppress
p
kay
york
uk
present
data
extend
publish
show
cellular
control
splenic
remodel
highli
compart
specif
although
inflammatori
monocyt
neg
matrix
metalloproteinas
posit
neutrophil
marker
neutrophil
respons
regul
vascular
chang
red
pulp
neither
popul
substanti
role
regul
destruct
follicular
dc
fibroblast
reticular
cell
white
pulp
use
model
mice
deplet
cell
chronic
infect
reconstitut
adopt
transfer
work
provid
new
insight
cell
regul
develop
helper
type
cell
immunopatholog
differ
act
larg
number
gene
divers
cell
unclear
present
c
mccoy
melbourn
australia
colleagu
built
publish
show
express
microrna
inhibit
microrna
link
modul
inflammatori
respons
inflammationinduc
cancer
pathogenesi
autoimmun
latest
work
suggest
regul
set
gene
previous
unknown
regul
cytokin
help
explain
biolog
potenc
work
also
strengthen
case
develop
therapeut
base
sure
microrna
regul
immun
respons
field
hostpathogen
interact
seen
discoveri
extend
far
beyond
greater
knowledg
pathogen
immunerespons
factor
multidisciplinari
approach
understand
complex
interact
pathogen
immun
respons
infect
led
heighten
appreci
adapt
pathogen
host
well
greater
insight
socal
steril
inflamm
innat
adapt
immun
control
autoimmun
first
lorn
infect
immun
confer
establish
bring
togeth
aspect
infect
pathogen
immun
respons
collabor
idea
result
discuss
meet
set
chang
way
research
view
infect
lead
improv
basic
knowledg
translat
better
treatment
prevent
infecti
inflammatori
diseas
look
forward
rapid
develop
field
second
lorn
infect
immun
confer
februari
